KOSPIChemicals017860

DS Dansuk

₩8,470 0.00%2026-11-18 close
Market Cap
₩149.5B
Turnover
₩400M
Volume
50K
Shares out.
17.7M
PER
—
PBR
0.6×
EPS
-₩1,418
Dividend Yield
0.12%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩10 per share · Prices as of the 2026-11-18 close

01

Report overview

Bio-fuel and recycling pivot: sales up, losses widening

DS Dansuk's sales have risen for three straight quarters, yet the company posted an operating loss of KRW 16.3 billion in the third quarter of 2026, so the gap between top-line recovery and profitability is the central issue.

  1. 1

    Third-quarter 2026 sales reached KRW 332.9 billion, the highest of the last five quarters, while the operating loss of KRW 16.3 billion was the largest loss in the same period.

  2. 2

    Annual sales fell for three straight years from 2023 to 2025, reaching KRW 954.9 billion in 2025, the smallest of 2022 to 2025.

  3. 3

    Net income attributable to controlling shareholders was negative in both 2024 and 2025, and the four quarters from Q4 2025 to Q3 2026 total a KRW 24.9 billion net loss attributable to controlling shareholders.

  4. 4

    Battery recycling sales reached KRW 321.8 billion in 2025, or 33.7% of consolidated sales, while the SAF feedstock plant and the Phillips 66 supply contract form the basis of the bio-energy growth axis.

  5. 5

    The debt ratio rose again to 180.8% at the end of 2025 from 155.7% in 2023, and operating cash flow fell from KRW 47.7 billion in 2024 to KRW 19 billion in 2025.

02

Business structure

DS Dansuk is a resource-recycling company that runs two segments, bio-energy and recycling, and has been listed on KOSPI since December 2023. According to a June 2026 press report, bio-energy accounted for 56.9% of sales, while recycling, covering batteries and plastics, accounted for 36.9%.

The bio-energy segment produces feedstock for bio-fuels such as biodiesel and bio-heavy oil, and the company introduced an enzyme reaction process from August 2025 to improve operating efficiency.

In November 2024 it completed a SAF PTU facility capable of producing 300,000 tons of SAF feedstock a year, and it aims to build a plant that can directly produce 300,000 tons of SAF annually by 2030.

Its contract with Phillips 66 of the United States covers supply of SAF feedstock worth KRW 1 trillion in total through November 2027. The recycling business began with secondary lead recovery from spent lead-acid batteries and has since expanded into copper and copper alloys and lithium-ion battery recycling.

Battery recycling sales rose each year, from KRW 251.6 billion in 2023 to KRW 270.6 billion in 2024 and KRW 321.8 billion in 2025, equal to 33.7% of consolidated sales in 2025.

In precious metal recovery (VMR), a newer business, the company shipped about 50 tons of PbAg bullion to Trafigura in June 2026 and recognized its first sales from that line. Company materials point to intense competition for raw material procurement as a factor limiting results.

The company also plans to pursue energy storage systems (ESS) and micro modular reactors (MMR) as new businesses.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩254.8B₩1.4B0.5%
2025Q4₩230.2B-₩1.1B−0.5%
2026Q1₩278.1B₩4.4B1.6%
2026Q2₩310.1B₩6.3B2.0%
2026Q3₩332.9B-₩16.3B−4.9%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩1.1T₩74B₩27.2B6.5%19.5%304.7%
2023₩1.1T₩76.2B₩40B7.1%14.4%155.7%
2024₩961.7B₩12.2B-₩9.2B1.3%−3.3%160.0%
2025₩954.9B₩8B-₩12B0.8%−4.4%180.8%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

Annual sales went from KRW 1.13 trillion in 2022 to KRW 1.07 trillion in 2023 (down 5.6% year on year), KRW 961.7 billion in 2024 (down 10.2%) and KRW 954.9 billion in 2025 (down 0.7%), falling for three straight years from 2023 to 2025. Among 2022 to 2025, 2022 was the largest sales year and 2025 the smallest.

Operating profit peaked at KRW 76.2 billion in 2023 (up 3.0% year on year), then fell to KRW 12.2 billion in 2024 (down 84.0%) and KRW 7.98 billion in 2025 (down 34.5%), declining for two straight years from 2024 to 2025.

The operating margin moved from 6.5% in 2022 and 7.1% in 2023 down to 1.3% in 2024 and 0.8% in 2025. The company attributed the 2025 decline mainly to a slump in the bio market caused by higher raw material prices.

Net income attributable to controlling shareholders reached KRW 40 billion in 2023 (up 47.2%), then swung to a net loss of KRW 9.16 billion in 2024 and widened to a net loss of KRW 12 billion in 2025. Net income including non-controlling interests was a net loss of KRW 10.3 billion in 2024 and KRW 12.1 billion in 2025.

Operating cash flow rose from KRW 510 million in 2022 to KRW 47.7 billion in 2024 before falling to KRW 19 billion in 2025. Quarterly sales bottomed at KRW 230.2 billion in Q4 2025, then rose to KRW 278.1 billion in Q1 2026, KRW 310.1 billion in Q2 and KRW 332.9 billion in Q3, increasing for three consecutive quarters.

Over the same stretch, operating profit was KRW 4.4 billion in Q1 2026 and KRW 6.29 billion in Q2, turning positive before Q3 swung to an operating loss of KRW 16.3 billion. According to press reports, the Q2 2026 turnaround came from the enzyme reaction process and higher bio-fuel export volumes. The Q3 2026 operating loss is the largest loss among the last five quarters.

05

Industry analysis

In Korea, the biodiesel blending mandate is set to rise to 8% by 2030, and internationally the IMO greenhouse gas rules for shipping and the ICAO carbon offsetting scheme are expected to lift demand for marine biofuel and SAF. POSCO Research Institute projects the global SAF market at KRW 92.4 trillion by 2030.

That demand outlook sits behind the company's medium-term plan to move from supplying SAF feedstock to direct SAF production. On the other side, the bio business was hit by higher raw material prices that depressed the market, and intense competition for feedstock procurement is cited as a constraint on results.

In cycle terms, the SAF feedstock facility is complete, but the direct production plant is still at the 2030 target stage, so the point at which industry conditions show up in earnings lies further ahead.

In recycling, rising volumes of electronic waste and growing metal demand are cited as an opportunity for rare metal exports. Compared with listed chemical peers, the company's mix of bio-fuel and spent battery recycling is the distinguishing feature.

Because raw material prices and policy-driven demand interact, the margin of the bio business depends on whether feedstock supply stabilizes.

06

Outlook

At its 2030 vision announcement the company set a sales target of KRW 3 trillion, and it said it has moved into technology upgrades and capacity expansion based on secured orders.

At its May 2026 investor briefing it presented SAF, precious metal recovery, ESS and micro modular reactors as core growth axes, describing a shift from a resource-recycling firm to an energy platform company.

By segment, the battery and plastic recycling business plans to raise utilization to improve unit costs, while the bio business plans to stabilize its feedstock supply chain and fully operate its enzyme catalysis reaction process.

The VMR precious metal alloy lead capacity is reported at 4,000 tons a year, and the company has a medium-term plan to move into higher value-added refining. The SAF feedstock supply contract with Phillips 66 runs through November 2027, and the supply structure after that date is the next checkpoint.

In August 2026 the company disclosed a share cancellation decision. The 2030 direct SAF plant, ESS and MMR businesses are still at the launch or planning stage, so the timing of their sales contribution will need to be confirmed through future disclosures.

The gap to the medium-term targets will become clearer when the next periodic report shows segment-level causes of the operating loss and the trend in raw material costs.

07

Valuation

PER
—
PBR
0.6×
ROE
-9.4%
EPS
-₩1,418
BPS
₩14,529
Dividend per share
₩10

Because the last four quarters carried cumulative net losses attributable to controlling shareholders, PER cannot be calculated. With earnings-based multiples unavailable, the price-to-book ratio becomes the main reference point.

The price-to-book ratio sits below 1x, which means the stock trades under book value per share. Earnings multiples from the years of profit cannot be applied directly to today's figures. The dividend yield is on the low side, so whether business profit recovers matters more than dividends in interpreting valuation.

At the end of 2025 total liabilities were KRW 488.8 billion against total equity of KRW 270.3 billion, a debt ratio of 180.8%, down from 304.7% in 2022 but up again since 2024. A share cancellation decision was disclosed in August 2026, so the direction of shareholder returns is also a point to confirm.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Three straight quarters of sales growth

After the Q4 2025 low, sales rose to KRW 278.1 billion in Q1 2026, KRW 310.1 billion in Q2 and KRW 332.9 billion in Q3. Q2 2026 operating profit of KRW 6.29 billion turned positive from a year-earlier operating loss, and press reports attributed this to the enzyme reaction process and higher export volumes. Whether sales growth carries through to profit recovery is the test for this bull case.

SAF feedstock contract and plant base

The Phillips 66 contract covers SAF feedstock worth KRW 1 trillion in total through November 2027, and a 300,000-ton-a-year SAF feedstock plant was completed in November 2024. The planned rise of the biodiesel blending mandate to 8% by 2030 is cited as a demand base. The 2030 target for a direct SAF production plant is the next step in widening that base.

Battery recycling and VMR portfolio

Battery recycling sales grew every year from KRW 251.6 billion in 2023 to KRW 321.8 billion in 2025, making up 33.7% of consolidated sales. The first VMR sales came from about 50 tons of PbAg bullion shipped to Trafigura in June 2026, and the reported capacity is 4,000 tons a year. A broader resource-recycling value chain is the basis for diversifying the earnings structure.

09

Bear factors

Two straight years of net losses and a Q3 operating loss

Net income attributable to controlling shareholders was negative in 2024 and 2025, and the last four quarters total a KRW 24.9 billion net loss attributable to controlling shareholders. The Q3 2026 operating loss of KRW 16.3 billion is the largest loss among the last five quarters. The core of the bear case is that higher sales have not yet translated into profit.

Financial burden and slower cash generation

The debt ratio rose from 155.7% in 2023 to 160.0% in 2024 and 180.8% in 2025. Total liabilities of KRW 488.8 billion exceed total equity of KRW 270.3 billion. Operating cash flow fell from KRW 47.7 billion in 2024 to KRW 19 billion in 2025, which narrows room for investment and debt repayment.

Raw material prices and feedstock competition

The company explained that higher raw material prices weighed on the bio market and were the main reason for the 2025 operating profit decline. Company materials point to intense feedstock procurement competition as limiting results.

The direct SAF plant, ESS and MMR are at the 2030 target or new-project stage, so their earnings contribution has yet to begin.

10

Risk factors

Feedstock and price risk

Margins in the bio business swing widely with raw material prices and feedstock competition. In 2025 higher raw material prices weighed on the bio market and reduced operating profit. Whether the plan to stabilize the feedstock supply chain produces actual cost improvement remains to be seen.

Execution risk

The KRW 3 trillion sales target for 2030 and the direct SAF plant of 300,000 tons a year are still at the target stage. ESS and micro modular reactors are new projects. Rising capital spending on new businesses could add financial strain, so funding and the timing of operations need to be read together.

Balance sheet risk

The debt ratio stood at 180.8% at the end of 2025, with total liabilities of KRW 488.8 billion. Operating cash flow fell to KRW 19 billion in 2025, and net losses attributable to controlling shareholders have accumulated over the last four quarters.

How the Phillips 66 SAF contract continues after November 2027 is a variable for the stability of the sales base.

11

What to watch next

  1. Mid-February 2027 (expected)

    Full-year 2026 preliminary results. The 2025 preliminary results were disclosed on February 13, 2026. The check is whether the Q3 operating loss carried into Q4 and where the full-year operating margin lands.

  2. Late March 2027 (expected)

    Filing of the 2026 annual report. Segment-level sales and operating profit will show the causes of the Q3 operating loss and the margin trend in the bio and recycling segments.

  3. Mid-May 2027 (expected)

    Q1 2027 results and quarterly report. The Q1 2026 report was filed on May 15, 2026. The check is whether the Q2 2026 turnaround holds and whether higher utilization in battery recycling improves unit costs.

  4. November 2027

    End of the Phillips 66 SAF feedstock contract period. Whether the contract is renewed and the supply volume thereafter will indicate the stability of the bio-energy sales base.

12

Overall view

DS Dansuk keeps its sales base on two pillars, bio-energy and battery recycling, and quarterly sales have risen for three straight quarters in 2026. Over the same period profitability swung back to an operating loss of KRW 16.3 billion in Q3 after the Q2 turnaround, so it is hard to describe the recovery as stable.

On an annual basis, sales fell for three straight years from 2023, operating profit declined for two straight years from 2024, and net losses attributable to controlling shareholders continued in 2024 and 2025.

Bull-side factors include the SAF feedstock contract with Phillips 66, growth in battery recycling sales and the first VMR shipments. Bear-side factors include raw material prices and feedstock competition, a rising debt ratio and lower operating cash flow.

With PER not calculable, valuation reads as a combination of the price-to-book ratio and whether business profit recovers. The next checkpoints are the full-year 2026 preliminary results, segment operating profit in the 2026 annual report and whether the Phillips 66 contract is renewed.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. comp.fnguide.com
  2. hanaw.com
  3. mt.co.kr
  4. mt.co.kr
  5. dealsite.co.kr
  6. ceoscoredaily.com
  7. news.nate.com
  8. comp.fnguide.com
  9. app.rndcircle.io
  10. news.samsung.com
  11. investing.com
  12. m.irgo.co.kr
  13. tradingkey.com
  14. insight.goover.ai
  15. judal.co.kr
  16. judal.co.kr
  17. judal.co.kr
  18. judal.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis